We have previously shown that ccRCC tumors can be classified into those with mutually exclusive mutations in BAP1 (and associated with high tumor grade, activation of mTORC1 and poor patient survival) and mutations in PBRM1 (and associated with better prognosis) [10,11,13]. Here, BAP1 is linked to nonpapillary renal cell carcinoma.